Print pageEmail pageRSS Feeds

We are building a strong, well-run business, structured to deliver sustainable results over the long term.

Along with biotechnology leadership, the ARIAD team is focused on its commitment to deliver long-term value to investors through solid business execution. That means maintaining disciplined cost control, thoughtful capital deployment and the highest standards of corporate governance.

Webcast ImageWebcast - Replay
J.P. Morgan Healthcare Conference
01/14/15 at 3:00 p.m. PT
J.P. Morgan Healthcare Conference
Wednesday, January 14, 2015 3:00 p.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Supporting Materials
Download Event Supporting Material J.P. Morgan Healthcare Conference
Recent Press Releases
More >>
01/22/15
ARIAD Announces Appointment of Thomas J. DesRosier, Senior Pharmaceutical-Industry Counsel, as Chief Legal and Administrative Officer
01/20/15
ARIAD Announces Final Decision from European Commission Endorsing Iclusig’s Approved Indications Throughout Europe
Investor Downloads

Download Documentation J.P. Morgan Healthcare Conference
More >>

ARIAD Stock Price: $6.10

Stock Symbol: ARIA

Stock Exchange: NASDAQ

Stock Quote at: 01/23/15

4:00 p.m. ET
(US Dollar)
CHANGE (%) Stock is Down 0.1 (1.61%)
VOL3,073,600
OPEN$6.18
PREV. CLOSE$6.20
DAY HIGH$6.23
DAY LOW$6.02
52 WK. HIGH$9.83
Minimum 20 minute delay
Refresh quote
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

You are now leaving this website. If you would like to continue, click Continue.
CancelContinue